Showing results (471-480 of 525) with videos related to

Sort By:
Pageof 53
Toxics|July 28, 2026
From Environmental Evidence to Biomarker Selection: A Structured Decision-Support Process for Human Biomonitoring Studies in Contaminated SitesElisa Bustaffa, Cristina Aprea, Alessandro Barbieri, et al.
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Medicina Clinica|March 5, 2004
[Blood pressure control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study]José L Llisterri Caro, Gustavo C Rodríguez Roca, Francisco J Alonso Moreno, et al.
International Journal of Cardiology|June 30, 2015
Prediction of development and maintenance of high albuminuria during chronic renin-angiotensin suppression by plasma proteomicsMontserrat Baldan-Martin, Fernando de la Cuesta, Gloria Alvarez-Llamas, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2009
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patientsAlejandro de la Sierra, Josep Redon, José R Banegas, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 17, 2023
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup AnalysisPantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, et al.
Oncotarget|June 1, 2017
Urinary exosomes reveal protein signatures in hypertensive patients with albuminuriaLaura Gonzalez-Calero, Paula J Martínez, Marta Martin-Lorenzo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE resultsRajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2022
Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular diseaseGerasimos Filippatos, Stefan D Anker, Bertram Pitt, et al.
Oncotarget|February 3, 2017
Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuriaFernando de la Cuesta, Montserrat Baldan-Martin, Rafael Moreno-Luna, et al.
Pageof 53